Literature DB >> 22234370

Potential interaction of brain natriuretic peptide with hyperadiponectinemia in preeclampsia.

Hisashi Masuyama1, Etsuko Nobumoto, Seiji Inoue, Yuji Hiramatsu.   

Abstract

Adiponectin was reported recently to have roles in the pathophysiology of preeclampsia. Moreover, elevation of adiponectin and brain natriuretic peptide (BNP) has been observed in preeclampsia. We examined the possible links between adiponectin and BNP in the pathophysiology of preeclampsia. We performed a cross-sectional study in 56 preeclampsia patients and 56 controls matched for gestational age and body mass index. The BNP, leptin, and adiponectin levels were measured by ELISA, and their mRNA expressions were evaluated in omental adipose tissue by real-time PCR. The effects of BNP on adiponectin and leptin mRNA expression and secretion were investigated in primary cultures of adipocytes from obese and normal-weight women. The BNP, adiponectin, and leptin levels were significantly higher in preeclampsia patients compared with controls. The adiponectin level was increased significantly in normal-weight preeclampsia patients compared with overweight preeclampsia patients. Adiponectin mRNA expression was increased significantly in adipose tissues of preeclampsia patients compared with controls and was also increased significantly in normal-weight preeclampsia patients compared with overweight preeclampsia patients, whereas leptin was not. BNP and adiponectin showed significant positive correlations in both normal-weight and overweight preeclampsia patients. BNP had a significantly weaker effect on adiponectin in overweight compared with normal-weight preeclampsia patients. Moreover, BNP had a weaker effect on adiponectin production in adipocytes from overweight women compared with adipocytes from normal-weight women using primary culture of human adipocytes. These data suggested that BNP may play a role in hyperadiponectinemia of preeclampsia patients. The weaker effect of BNP on adiponectin production may participate in the pathophysiology of overweight preeclampsia patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234370     DOI: 10.1152/ajpendo.00548.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  3 in total

1.  Metabolism in pregnancy: a field for novel therapies.

Authors:  Nikolaos Vrachnis; Dimitrios Zygouris; Sophia Kalantaridou; Zoe Iliodromiti
Journal:  Nat Rev Endocrinol       Date:  2014-03-11       Impact factor: 43.330

2.  Differences in uterine artery blood flow and fetal growth between the early and late onset of pregnancy-induced hypertension.

Authors:  Takashi Mitsui; Hisashi Masuyama; Jota Maki; Shoko Tamada; Yumika Hirano; Eriko Eto; Etsuko Nobumoto; Kei Hayata; Yuji Hiramatsu
Journal:  J Med Ultrason (2001)       Date:  2016-06-28       Impact factor: 1.314

Review 3.  Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis.

Authors:  Lisa J Alma; Anouk Bokslag; Angela H E M Maas; Arie Franx; Walter J Paulus; Christianne J M de Groot
Journal:  ESC Heart Fail       Date:  2017-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.